| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| GTO ID | GTC2938 |
| Trial ID | NCT05243212 |
| Disease | Multiple Myeloma |
| Altered gene | BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CAR-BCMA |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Study of CAR-BCMA, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against BCMA in Subjects With Multiple Myeloma |
| Year | 2022 |
| Country | Israel |
| Company sponsor | Sheba Medical Center |
| Other ID(s) | SHEBA-21-8048-HM-CTIL |
| Cohort 1 | |||||||||||
|
|||||||||||